辉瑞:2 款创新 ADC 联合 K 药数据首次公布!恩扎卢胺 5 年 OS 率超 65 %...

Insight数据库
31 May

2025 年 ASCO 大会火热进行中,辉瑞带来了60 多项重磅临床研究成果,包括15 篇口头和快速口头报告,适应症覆盖乳腺癌、泌尿生殖系统癌症、血液系统癌症、胸腔癌以及结直肠癌。本文将挑选部分进行具体介绍,供读者参考。由于文章篇幅有限,难以纳入所有重要研究结果。欢迎使用 Insight 数据库进行查阅(长按文末二维码即可免费试用哦~)。5年 OS 率达 66%恩扎卢胺前列腺癌 III 期数据更新...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10